04.11.2020 • News

Sanofi is Overall Winner of ISPE’s 2020 Facility of the Year Awards

The International Society for Pharmaceutical Engineering (ISPE) has announced Sanofi as the 2020 Facility of the Year Awards (FOYA) Overall Winner.

The FOYA program each year recognizes state-of-the-art projects utilizing new, innovative technologies to improve the quality of products, reduce the cost of producing high-quality medicines, and demonstrate advances in project delivery.

Sanofi was awarded the Facility of the Future Category Award in April 2020 for its Sanofi Digitally Enabled Integrated Continuous Biomanufacturing Facility in Framingham, Massachusetts, USA. This fully integrated bioprocessing facility takes the application of disposable process technology and flexible facility design to a new level. Using the best of already proven technology and design, they have expanded the use to allow design and construction of a facility that enables continuous upstream and downstream processing, said ISPE.

Sanofi has achieved a facility with higher capacity in a smaller footprint than traditionally achievable. This has provided the basis for:

  • 80 times more production capacity than traditionally achieved, leading to potentially reaching more patients
  • More than 90% reduction in chemical usage per year
  • More than 90% reduction in water usage per year
  • 80% reduction in energy consumption and CO2 emissions per year
  • More than 320 t/y of waste saved from landfills

From the early design phases Sanofi was dedicated to incorporating a full set of lean operations principles into the design. According to ISPE, they have broken new ground in digital integration. The entire facility is run using a comprehensive suite of digital solutions.

Sanofis Digitally Enabled Integrated Continuous Biomanufacturing Facility in...
Sanofi's Digitally Enabled Integrated Continuous Biomanufacturing Facility in Framingham, Massachusetts, USA. Source: Sanofi

Interview

The UK Chemical Supply Chain
Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.